4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-046423
Chief Financial Officer sold 50,000 shares at an average $9.09 ($454,310)
- Chief Financial Officer acquired 75,000 shares (option exercise)
- Chief Financial Officer gave up 4,727 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Secora Michael · Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-15 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −4,727 | $9.19 | $43,441 | 838,186 | D |
| 2023-08-15 | Exercise or conversion : show line 2 in the form 10b5-1 | +37,500 | $2.22 | $83,250 | 875,686 | D |
| 2023-08-15 | Sale : show line 3 in the form 10b5-1 | −25,000 | $9.27 | $231,793 | 850,686 | D |
| 2023-08-16 | Exercise or conversion : show line 4 in the form 10b5-1 | +37,500 | $2.22 | $83,250 | 888,186 | D |
| 2023-08-16 | Sale : show line 5 in the form 10b5-1 | −25,000 | $8.90 | $222,518 | 863,186 | D |
| Open-market sales · 50,000 sh · avg $9.09 · $454,310 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −37,500 | $2.22 | 2030-03-03 | 37,500 | 1,485,135 | D |
| 2023-08-16 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −37,500 | $2.22 | 2030-03-03 | 37,500 | 1,410,135 | D |
Loading xslF345X05/doc4.xml…